Get the app
US › Healthcare

Exicure Inc (XCUR)

US · Healthcare · Biotechnology

$1.120.00%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-1.1M
EPS
$-0.18

Key statistics

Market cap
$7.3M
Forward P/E
0.0
P/B
8.44
Book value
$0.15
EPS (TTM)
$-1.31
52-week high
$9.48
52-week low
$0.94
50-day MA
$1.25
200-day MA
$2.96
Beta
3.64

Analyst view

with an average price target of $2.00.

Shareholding

Insiders
41.47%
Institutions
2.25%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC0.66%
Geode Capital Management, LLC0.48%
Jane Street Group LLC0.45%
Citadel Advisors Llc0.23%
Vanguard Fiduciary Trust Co0.20%
Tower Research Capital LLC0.06%
UBS Group AG0.01%
Morgan Stanley - Brokerage Accounts0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Exicure Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.